Menu Close

Ongoing Efforts Seek to Refine, Expand CAR T-Cell Therapy

The recent advances with chimeric antigen receptor (CAR) T-cell therapy in select hematologic malignancies have been exciting; however, more research is needed to move these treatments into an earlier treatment setting and drive down their costs, according … (본문 전체 10/9/2018 3:58 AM)